AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.11
+0.09 (1.79%)
At close: Jul 25, 2025, 4:00 PM
5.12
+0.01 (0.20%)
After-hours: Jul 25, 2025, 7:59 PM EDT

AbCellera Biologics Stock Forecast

Stock Price Forecast

The 5 analysts that cover AbCellera Biologics stock have a consensus rating of "Strong Buy" and an average price target of $8.75, which forecasts a 71.23% increase in the stock price over the next year. The lowest target is $5 and the highest is $10.

Price Target: $8.75 (+71.23%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$5.00$8.75$10$10
Change-2.15%+71.23%+95.69%+95.69%

Analyst Ratings

The average analyst rating for AbCellera Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111222
Buy111112
Hold111111
Sell000000
Strong Sell000000
Total333445

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Keybanc
Keybanc
Buy
Maintains
$5$10
BuyMaintains$5$10+95.69%Jul 14, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$5
BuyInitiates$5-2.15%Jul 7, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$28$10
Strong BuyMaintains$28$10+95.69%May 16, 2025
Keybanc
Keybanc
Buy
Maintains
$4$5
BuyMaintains$4$5-2.15%Apr 16, 2025
Benchmark
Benchmark
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
21.57M
from 28.83M
Decreased by -25.19%
Revenue Next Year
36.91M
from 21.57M
Increased by 71.11%
EPS This Year
-0.68
from -0.55
EPS Next Year
-0.59
from -0.68
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
233.16M375.20M485.42M38.03M28.83M21.57M36.91M46.92M
Revenue Growth
1,907.88%60.92%29.38%-92.17%-24.17%-25.19%71.11%27.11%
EPS
0.450.480.50-0.51-0.55-0.68-0.59-0.72
EPS Growth
-6.21%4.17%-----
Forward PE
--------
No. Analysts
-----1196
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High27.5M60.9M72.5M
Avg21.6M36.9M46.9M
Low15.7M28.5M30.2M

Revenue Growth

Revenue Growth20252026202720282029
High
-4.6%
182.3%
96.3%
Avg
-25.2%
71.1%
27.1%
Low
-45.5%
31.9%
-18.2%

EPS Forecast

EPS20252026202720282029
High-0.61-0.29-0.59
Avg-0.68-0.59-0.72
Low-0.74-0.79-0.81

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.